Public Company News
Novavax Announces Launch of Global Vaccine Education Programs
- 'We Do Vaccines' and 'Know Our Vax' are new educational efforts that provide information regarding vaccines - Programs explain Novavax' commitment to vaccine development and innovation GAITHERSBURG, Md., March 10, 2022 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company de...
2022-03-10 22:00
5434
Bigtincan Wins Silver Stevie® Award for its Sales Enablement Solution
Leader in sales enablement automation takes home 7th Stevie Award for Sales & Customer Service WALTHAM, Mass., March 10, 2022 /PRNewswire/ -- Bigtincan (ASX: BTH), the global leader in sales enablement automation, today announced the company has won a Silver 2022 Stevie® Award for the Sales Enab...
2022-03-10 21:00
3774
BNY Mellon Announces Leadership Succession Plan Naming Robin Vince CEO-Elect
CEO Todd Gibbons to Retire This Year Robin Vince, Vice Chair of BNY Mellon and CEO of Global Market Infrastructure, Named President and CEO-elect NEW YORK, March 10, 2022 /PRNewswire/ -- The Bank of New York Mellon Corporation ("BNY Mellon") (NYSE: BK) announced today thatThomas P. (Todd) Gibbo...
2022-03-10 20:30
6212
Infineon and Sleepiz enable high-precision sleep monitoring at home based on radar technology
MUNICH, March 10, 2022 /PRNewswire/ -- Billions of people are facing sleep problems. According to scientific research[1], about one billion people alone suffer from sleep apnea, an interrupted breathing during the night. This is leading to various health consequences including snoring, daytime fa...
2022-03-10 19:49
5335
Everest Medicines Announces that Licensing Partner Venatorx Pharmaceuticals Reports Positive Results from Pivotal Phase 3 Cefepime-Taniborbactam Trial
SHANGHAI, March 10, 2022 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK) announced today that its licensing partner, Venatorx Pharmaceuticals, reported positive results from its pivotal Phase 3 study, CERTAIN-1 (Cefepime Rescue with Taniborbactam in cUTI), evaluating cefepime-taniborbactam, an in...
2022-03-10 19:05
4810
Infosys Becomes Digital Innovation Partner for International Tennis Hall of Fame and Title Sponsor of the Hall of Fame Open
Strategic collaboration to bring technology expertise to reimagine fan
experiences and preserve tennis heritage at the historic venue where the first
U.S. National Championships were hosted in 1881
NEWPORT, R.I., March 10, 2022 /PRNewswire/ -- Infosys
2022-03-10 18:49
4067
Fosun Foundation's Second Batch of More Than 500,000 Pieces of Anti-epidemic Materials Arrives in Hong Kong Successively to Aid High-risk Groups and Grassroots Families
HONG KONG, March 10, 2022 /PRNewswire/ -- In the face of the severe fifth wave of epidemic inHong Kong, Fosun Foundation quickly launched the epidemic relief work of "Let's Work Hand in Hand and Combat the Epidemic Together" inHong Kong. After the first batch of 250,000 sets of COVID-19 rapid ant...
2022-03-10 14:25
4288
GOODWE CHANGES BRAND GUIDELINE WITH MORE COOPERATION OPPORTUNITIES
HANOI, Vietnam, March 10, 2022 /PRNewswire/ -- On January 7, 2022, GoodWe, the world's leading manufacturer of energy storage solutions and solar inverters, officially changed its brand identity to match the development trend of the renewable energy industry. The core of the rebranding is GoodWe'...
2022-03-10 13:15
4812
SleekFlow, an Alibaba-backed all-in-one social commerce software continues to build a strong team in SEA, seizing upon this era of social distancing
SINGAPORE, March 10, 2022 /PRNewswire/ -- SleekFlow
2022-03-10 10:30
7354
Antengene Announces IND Approval in China for the Phase I Study of ATG-101 (PD-L1/4-1BB Bispecific Antibody) for the Treatment of Solid Tumors and Non-Hodgkin Lymphoma
- The novel bispecific antibody ATG-101 is Antengene's first in house developed molecule with global rights. - This approval in China marks the third regulatory clearance granted to ATG-101 globally. - Upon receiving clearances in Australia and the U.S. in 2021, the Phase I study of ATG-101 ...
2022-03-10 08:52
5006
Transcenta Presented Safety / Tolerability and Preliminary Anti-tumor Activity Data in Gastric and Pancreatic Cancers of TST001 Monotherapy from China Phase I Clinical Trial at the 2022 International Gastric Cancer Congress
SUZHOU, China, March 10, 2022 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development and manufacturing of antibody-based therapeutics, announces that Transcenta has ...
2022-03-10 08:30
4445
Sofwave Medical LTD reports financial results for the full year 2021 with accelerated growth in revenues and gross margin
Revenue increased in 2021 to $21.8M vs. $4.3M in 2020 2021 second-half revenue increased to $11.7M vs. $3.5M in the second half of 2020 Record Q4 2021 revenues of $8.9M Revenue from pulses for the full year 2021 increased to $2.6M TEL AVIV, Israel, March 9, 2022 /PRNewswire/ -- Mr. Lou Scafuri,...
2022-03-09 23:20
2654
New Tough Off-road Contender--GWM TANK300 Arrives Now
BAODING, China, March 9, 2022 /PRNewswire/ -- Recently, according to the 2021
sales report of GWM, GWM TANK300 has an outstanding market share, accounting
for more than 50% of the tough off-road market inChina.
2022-03-09 21:59
10603
SOPHiA GENETICS HRD Solution Adopted in Asia Pacific
BOSTON, LAUSANNE, Switzerland and TAIPEI CITY, Taiwan, March 9, 2022 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH) today announced that SOFIVA GENOMICS, which is one of the largest genetic testing companies inTaiwan aiming to provide genetic testing to clinicians, is the first institution inAsia...
2022-03-09 21:57
3313
New Virtual Selling and Coaching Technologies from Bigtincan Allow Organizations to Bring the Metaverse and Web 3.0 Technologies to Sales Teams and Customers
New Features Dramatically Improve Engagement in Virtual Environments WALTHAM, Mass., March 9, 2022 /PRNewswire/ -- Bigtincan® (ASX:BTH), the global leader in sales enablement automation, today announced the availability of a set of technologies that allow organizations to bring Metaverse and Web...
2022-03-09 21:00
2098
Antengene Announces Five Upcoming Presentations at the 2022 American Association for Cancer Research Annual Meeting
* Posters Showcase Early-Stage Clinical and Preclinical Pipeline. * Focus on ATG-037, ATG-018, ATG-022, ATG-012 and ATG-008. SHANGHAI and HONG KONG, March 9, 2022 /PRNewswire/ -- Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading innovative, global biopharmaceutical company ...
2022-03-09 20:00
5176
InsurTech Carrot Distributes Distance-based Auto Insurance To More Than Half A Million Consumers
SEOUL, South Korea, March 9, 2022 /PRNewswire/ -- A leading insurance technology platform Carrot General Insurance Corp. ("Carrot" or the "Company"), today announced that it has sold more than 500 thousand policies for its flagship pay-per-mile usage-based (UBI) auto insurance program. Having ...
2022-03-09 19:57
5391
New IBM Cybersecurity Hub to help Asia Pacific organizations build Cyber resiliency
- IBM Security Command Center in India represents significant investment in security incident response and training for organizations across APAC - Asia was #1 most-targeted region for cyberattacks in 2021, according to IBM Security X-Force Threat Intelligence Index, released today MANILA, Phili...
2022-03-09 19:35
6030
Antengene Announces XPOVIO® Approved by the TGA in Australia for the Treatment of Relapsed and/or Refractory Multiple Myeloma and Triple Class-Refractory Multiple Myeloma
- XPOVIO®, in combination with bortezomib and dexamethasone (XBd), gives patients with relapsed and/or refractory multiple myeloma, a new treatment option. - XPOVIO®, in combination with dexamethasone (Xd), gives patients with triple class refractory multiple myeloma, a new treatment option. ...
2022-03-09 19:08
4214
Trina Solar featured in independent agency report: With superior value, large-format modules will account for about 80% of market share this year
CHANGZHOU, China, March 9, 2022 /PRNewswire/ -- Ultra-high power modules have quickly become a mainstream market choice, something that has been perceivable in the photovoltaic industry since last year. The New Technology Market Report published in February by PV InfoLink, a division of independe...
2022-03-09 16:42
5468
Week's Top Stories
Most Reposted
HLB Customers Can Now Scan & Pay in China with HLB QR Pay
[Picked up by 294 media titles]
2026-10-22 22:35
SALMON SECURES $140 MILLION (PHP 8.8 BILLION) TO DOUBLE DOWN ON THE GROWTH OPPORTUNITY IN THE PHILIPPINES
[Picked up by 283 media titles]
2026-10-19 13:18
TCL Zhonghuan Powers India's Energy Transition with PV Innovations at REI Expo 2026
[Picked up by 278 media titles]
2026-10-23 21:52
Infobip and Yamaha Power Conversational Customer Engagement in Indonesia's Automotive Sector
[Picked up by 276 media titles]
2026-10-21 15:00
DayOne Supports NVIDIA DSX POD Reference Design, Advancing Standardized Infrastructure for AI
[Picked up by 271 media titles]
2026-10-22 11:55Most Read
Hi3D V1.0 Goes Open Source: The First Production-Validated Open-Source AI 3D Model
2026-10-23 23:30
30881
Home 3D Printers are More Accessible Than Ever This Black Friday with Bambu Lab
2026-10-22 17:00
26337
BeautyPlus Web Launches Halloween Photo Booth With Behind-the-Scenes Video Export
2026-10-23 01:00
24313
Cuttable Unveils Next-Generation AI Advertising Platform as U.S. Expansion Accelerates
2026-10-24 00:00
24286